KIDNEY CARE COUNCIL

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

$18.3M

Filings

282

Firms Hired

Active Period

2001–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$85,000	5	3
2025	$330,000	11	3
2024	$525,000	11	2
2023	$240,000	8	2
2022	$350,000	9	2
2021	$690,000	10	2
2020	$480,000	8	2
2019	$480,000	9	3
2018	$940,000	16	4
2017	$650,000	18	5
2016	$1,080,000	16	4
2015	$1,290,000	17	4
2014	$1,620,000	24	6
2013	$1,100,000	17	4
2012	$1,040,000	12	3
2011	$990,000	12	3
2010	$830,000	13	3
2009	$890,000	13	3
2008	$2,195,000	17	4
2007	$1,960,000	12	5
2006	$500,000	11	5
2005	—	4	2
2004	—	4	2
2003	—	2	1
2002	—	1	1
2001	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE KIDNEY CARE COUNCIL	$18,265,000	89
ALSTON & BIRD LLP	—	50
SQUIRE PATTON BOGGS	—	40
LESTER HEALTH LAW PLLC	—	50
AVENUE SOLUTIONS	—	17
LINCOLN POLICY GROUP	—	9
TARPLIN, DOWNS & YOUNG, LLC	—	7
COZEN O'CONNOR PUBLIC STRATEGIES	—	6
RS GROUP CONSULTING LLC	—	6
ABERNATHY CONSULTANTS CATHY	—	4
AKIN GUMP STRAUSS HAUER FELD	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	232
SENATE	225
Centers For Medicare and Medicaid Services (CMS)	209
Health & Human Services, Dept of (HHS)	76
Medicare Payment Advisory Commission (MedPAC)	49
White House Office	28
Office of Management & Budget (OMB)	22
Centers For Disease Control & Prevention (CDC)	18
Treasury, Dept of	5
Veterans Affairs, Dept of (VA)	4
Natl Economic Council (NEC)	3
Executive Office of the President (EOP)	1
UNDETERMINED	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	254
Health Issues	Health Issues	198
Budget/Appropriations	Budget/Appropriations	6
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	5
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	4

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2199119th Congress

Restore Protections for Dialysis Patients Act

2026 · third_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: H.R.2199

S. 1173119th Congress

Restore Protections for Dialysis Patients Act

2026 · third_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: S.1173

H.R. 2199119th Congress

Restore Protections for Dialysis Patients Act

2026 · second_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: H.R.2199

S. 1173119th Congress

Restore Protections for Dialysis Patients Act

2026 · second_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: S.1173

Show 21 more cited filings

H.R. 2199119th Congress

Restore Protections for Dialysis Patients Act

2026 · first_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: H.R.2199

S. 1173119th Congress

Restore Protections for Dialysis Patients Act

2026 · first_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: S.1173

H.R. 2199119th Congress

Restore Protections for Dialysis Patients Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: HR 2199

H.R. 2199119th Congress

Restore Protections for Dialysis Patients Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: HR 2199

H.R. 6214119th Congress

Kidney Care Access Protection Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: HR 6214

H.R. 6214119th Congress

Kidney Care Access Protection Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: HR 6214

S. 1173119th Congress

Restore Protections for Dialysis Patients Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: S.1173

S. 1173119th Congress

Restore Protections for Dialysis Patients Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: S.1173

S. 2730119th Congress

Kidney Care Access Protection Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: S 2730

S. 2730119th Congress

Kidney Care Access Protection Act

2026 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Health policy related to kidney, renal, and dialysis care. Including, Medicare reimbursement, coverage, and policies pursuant to the Medicare End Stage Renal Disease (ESRD) Prospective Payment System (PPS); bundling of certain oral-only drugs to the ESRD PPS; support for innovative therapies for patients living with kidney disease. KCC supports the Kidney Care Access Protection Act (HR 6214, S 2730) which addresses some of these issues. Medicare Secondary Payer issues to protect patient choice of coverage for individuals with ESRD, including support for the Restore Protections for Dialysis Patients Act (HR 2199, S.1173.). Introduction to Kidney Care Council as an organization, our member companies, and the patients they serve.

Client expense: $85,000 · Firm income: —

Matched citations: S 2730

H.R. 2199119th Congress

Restore Protections for Dialysis Patients Act

2025 · fourth_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: H.R.2199

S. 1173119th Congress

Restore Protections for Dialysis Patients Act

2025 · fourth_quarter · Firm: RS GROUP CONSULTING LLC

Open original LDA filing ↗

Cited source text and reported amounts

General ESRD education; S.1173/H.R.2199, the Restore Protections for Dialysis Patients Act

Client expense: — · Firm income: $30,000

Matched citations: S.1173

H.R. 5027118th Congress

Chronic Kidney Disease Improvement in Research and Treatment Act of 2023

2024 · fourth_quarter · Firm: LESTER HEALTH LAW PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; ESRD PPS; Medicare Secondary Payer; ESRD quality programs; HR 5027 Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; S 4469 the Chronic Kidney Disease Improvement in Research and Treatment Act of 2024; ESRD PPS proposed rulemaking CY 2025; Medicare Advantage Rate Announcement; Medicare Advantage FY25 proposed rule

Client expense: — · Firm income: $30,000

Matched citations: HR 5027

H.R. 6860118th Congress

Restore Protections for Dialysis Patients Act

2024 · fourth_quarter · Firm: LESTER HEALTH LAW PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 6860, "Restore Protections for Dialysis Patients Act"

Client expense: — · Firm income: $30,000

Matched citations: H.R. 6860

S. 4469118th Congress

Chronic Kidney Disease Improvement in Research and Treatment Act of 2024

2024 · fourth_quarter · Firm: LESTER HEALTH LAW PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; ESRD PPS; Medicare Secondary Payer; ESRD quality programs; HR 5027 Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; S 4469 the Chronic Kidney Disease Improvement in Research and Treatment Act of 2024; ESRD PPS proposed rulemaking CY 2025; Medicare Advantage Rate Announcement; Medicare Advantage FY25 proposed rule

Client expense: — · Firm income: $30,000

Matched citations: S 4469

H.R. 5074118th Congress

Kidney PATIENT Act of 2023

2024 · third_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; End Stage Renal Disease Prospective Payment System; Medicare Secondary Payer; ESRD quality programs; workforce and labor, ESRD PPS forecast error, Medicare Physician Fee Schedule Provider Enrollment Issues, closures of dialysis facilities and concerns regarding access to care for Americans living with kidney failure, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act of 2023 (H.R. 5074).

Client expense: $75,000 · Firm income: —

Matched citations: H.R. 5074

H.R. 5074118th Congress

Kidney PATIENT Act of 2023

2024 · third_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; End Stage Renal Disease Prospective Payment System; Medicare Secondary Payer; ESRD quality programs; workforce and labor, ESRD PPS forecast error, Medicare Physician Fee Schedule Provider Enrollment Issues, closures of dialysis facilities and concerns regarding access to care for Americans living with kidney failure, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act of 2023 (H.R. 5074).

Client expense: $75,000 · Firm income: —

Matched citations: H.R. 5074

H.R. 5074118th Congress

Kidney PATIENT Act of 2023

2024 · second_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; End Stage Renal Disease Prospective Payment System; Medicare Secondary Payer; ESRD quality programs; workforce and labor, ESRD PPS forecast error, Medicare Physician Fee Schedule Provider Enrollment Issues, closures of dialysis facilities and concerns regarding access to care for Americans living with kidney failure, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act of 2023 (H.R. 5074).

Client expense: $75,000 · Firm income: —

Matched citations: H.R. 5074

H.R. 5074118th Congress

Kidney PATIENT Act of 2023

2024 · second_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; End Stage Renal Disease Prospective Payment System; Medicare Secondary Payer; ESRD quality programs; workforce and labor, ESRD PPS forecast error, Medicare Physician Fee Schedule Provider Enrollment Issues, closures of dialysis facilities and concerns regarding access to care for Americans living with kidney failure, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act of 2023 (H.R. 5074).

Client expense: $75,000 · Firm income: —

Matched citations: H.R. 5074

H.R. 5074118th Congress

Kidney PATIENT Act of 2023

2024 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; End Stage Renal Disease Prospective Payment System; Medicare Secondary Payer; ESRD quality programs; workforce and labor, ESRD PPS forecast error, Medicare Physician Fee Schedule Provider Enrollment Issues, closures of dialysis facilities and concerns regarding access to care for Americans living with kidney failure, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act of 2023 (H.R. 5074).

Client expense: $75,000 · Firm income: —

Matched citations: H.R. 5074

H.R. 5074118th Congress

Kidney PATIENT Act of 2023

2024 · first_quarter · Firm: THE KIDNEY CARE COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

Kidney Care reimbursement issues; End Stage Renal Disease Prospective Payment System; Medicare Secondary Payer; ESRD quality programs; workforce and labor, ESRD PPS forecast error, Medicare Physician Fee Schedule Provider Enrollment Issues, closures of dialysis facilities and concerns regarding access to care for Americans living with kidney failure, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act of 2023 (H.R. 5074).

Client expense: $75,000 · Firm income: —

Matched citations: H.R. 5074

Source: Senate LDA

KIDNEY CARE COUNCIL — Lobbying Disclosure | Poliscope